HuGE Literature Finder
Records 1-11
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
Reproductive sciences (Thousand Oaks, Calif.) 2020 Jan . Malentacchi Francesca, Turrini Irene, Sorbi Flavia, Projetto Elisabetta, Castiglione Francesca, Vergoni Federica, Amunni Gianni, Fambrini Massimiliano, Petraglia Felice, Noci Ivo, Pillozzi Sere |
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago and California Consortia (NCI9322/PHL86).
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Jan . Dhani Neesha C, Hirte Hal W, Wang Lisa, Burnier Julia V, Jain Angela, Butler Marcus O, Welch Stephen, Fleming Gini F, Hurteau Jean, Matsuo Koji, Matei Daniela, Jimenez Waldo, Johnston Carolyn, Cristea Mihaela, Tonkin Katia, Ghatage Prafull, Lheureux Stephanie, Mehta Anjali, Quintos Judy, Tan Qian, Kamel-Reid Suzanne, Ludkovski Olga, Tsao Ming-Sound, Wright John J, Oza Amit |
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Gynecologic oncology 2019 Jul . Cybulska Paulina, Paula Arnaud Da Cruz, Tseng Jill, Leitao Mario M, Bashashati Ali, Huntsman David G, Nazeran Tayyebeh M, Aghajanian Carol, Abu-Rustum Nadeem R, DeLair Deborah F, Shah Sohrab P, Weigelt Brit |
Efficacy of liquid-based genetic diagnosis of endometrial cancer.
Cancer science 2018 Oct . Matsuura Motoki, Yamaguchi Kiyoshi, Tamate Masato, Satohisa Seiro, Teramoto Mizue, Iwasaki Masahiro, Sugita Shintaro, Hasegawa Tadashi, Koubo Rika, Takane Kiyoko, Ikenoue Tsuneo, Furukawa Yoichi, Saito Tsuyos |
Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer.
Oncotarget 2017 Mar . van Esterik Manouk, Van Gool Inge C, de Kroon Cor D, Nout Remi A, Creutzberg Carien L, Smit Vincent T H B M, Bosse Tjalling, Stelloo Ell |
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Gynecologic oncology 2016 Apr 141 (1): 43-8. Myers Andrea P, Filiaci Virginia L, Zhang Yuping, Pearl Michael, Behbakht Kian, Makker Vicky, Hanjani Parviz, Zweizig Susan, Burke James J, Downey Gordon, Leslie Kimberly K, Van Hummelen Paul, Birrer Michael J, Fleming Gini |
Genetic alterations in endometrial cancer by targeted next-generation sequencing.
Experimental and molecular pathology 2015 Nov . Chang Ya-Sian, Huang Hsien-Da, Yeh Kun-Tu, Chang Jan-Gow |
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jun 28 (6): 836-44. Stelloo Ellen, Bosse Tjalling, Nout Remi A, MacKay Helen J, Church David N, Nijman Hans W, Leary Alexandra, Edmondson Richard J, Powell Melanie E, Crosbie Emma J, Kitchener Henry C, Mileshkin Linda, Pollock Pamela M, Smit Vincent T, Creutzberg Carien |
Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome.
Cancer 2013 Aug 119 (16): 3027-33. Huang Marilyn, Djordjevic Bojana, Yates Melinda S, Urbauer Diana, Sun Charlotte, Burzawa Jennifer, Daniels Molly, Westin Shannon N, Broaddus Russell, Lu Kar |
FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features.
PloS one 2012 7 (2): e30801. Byron Sara A, Gartside Michael, Powell Matthew A, Wellens Candice L, Gao Feng, Mutch David G, Goodfellow Paul J, Pollock Pamela |
Molecular analysis of endometrial pathogenesis in Lynch syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 5095. Huang M, Djordjevic B, Urbauer D, Westin S N, Sun C C, Burzawa J K, Meyer L, Bodurka D C, Broaddus R, Lu K |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: